Le Lézard
Classified in: Health, Science and technology
Subjects: AWD, TDS

Ambra Health Named 2018 Finalist for Fierce Healthcare Innovation Award


NEW YORK, Nov. 15, 2018 /PRNewswire/ -- Ambra Health, makers of the leading cloud-based, medical image management suite, today announced that Ambra Suite was named as one of three Fierce Health Innovation Award finalists in the Clinical Information Management Category.

Ambra Health Logo (PRNewsfoto/Ambra Health)

Ambra Health is at the forefront of the transformation of medical imaging research through cloud technology. The flexibility inherent in a cloud platform allows providers to receive and exchange imaging within and across networks, provide a unified source of imaging data for enhanced access and disaster recovery planning, and deliver a suite of tools to enhance patient care and clinical research in imaging, including AI and machine learning. Ambra Health's open API and Cloud PACS for Research allow facilities to centrally manage and automate workflows, deploy an integrated application fabric, and accelerate moving data sets. With leading customers in the life sciences and provider area, Ambra connects more than 1,500 healthcare organizations and manages more than four billion images through the platform.

"Imaging is the source of truth data, which can make the critical difference in diagnostic outcomes," said Morris Panner, CEO of Ambra Health. "We enable providers, payers, and researchers to gain access to critical patient information as well as the appropriate tool sets for collaboration and research."

The Fierce Innovation Awards: Healthcare Edition will identify and showcase outstanding innovation that is driving improvements and transforming the industry. Applications are judged by industry experts and evaluated based on the following criteria: effectiveness, technical innovation, competitive advantage, financial impact, and true innovation. Winners will be announced and featured in the Innovation Report scheduled to publish on Thursday, December 13, 2018.

Ambra Health was recently recognized by KLAS Research as the top medical image exchange vendor for the fourth year in a row and named Startup-of-the-Year in the SIIA Company CODiE Awards. Those interested in learning more about Ambra Health's imaging solutions, including the new Ambra mobile application and patient portal features, can receive a live demo at Booth #1122 during the upcoming RSNA conference. To make an appointment or for more detail, visit the Ambra Health website.

About Ambra Health
Ambra Health is a medical data and image management SaaS company. Intuitive, flexible, scalable and highly interoperable, the Ambra cloud platform is designed to serve as the backbone of imaging innovation and progress for healthcare providers. It empowers some of the largest health systems such as Memorial Hermann and New England Baptist Hospital as well as radiology practices, subspecialty practices, and clinical research organizations to dramatically improve imaging and collaborative care workflows. As expert partners, we listen to our customers, understand their needs, and apply our extensive knowledge to deliver innovative medical image management solutions for the future of healthcare, now. Discover what the Ambra medical imaging cloud can do for you at www.ambrahealth.com.

SOURCE Ambra Health


These press releases may also interest you

at 12:05
Terragia Biofuel, a technology startup aiming to drive the next generation of biofuels, today announced it has raised a $6 million seed round led by Engine Ventures and Energy Impact Partners (EIP). The company will use the capital to commercialize...

at 12:00
V-Wave today announced it will present late-breaking data from its RELIEVE-HF pivotal trial at the American College of Cardiology's (ACC) Annual Scientific Session & Expo taking place April 6-8 in Atlanta. RELIEVE-HF is a randomized, double-blind,...

at 12:00
Critical Path Institute's (C-Path) Duchenne Regulatory Science Consortium (D-RSC) is excited to announce the launch of a groundbreaking model-based Clinical Trial Simulator (CTS), specifically designed to improve design of efficacy studies for...

at 11:45
SummaryProduct: Henna cones Issue: Chemical hazard / Product safety What to do: Stop using and selling them immediately and dispose of them in regular household garbage Who this is for: General public / Industry; Retail, Importers IssueHealth Canada...

at 11:30
The "Global Antibody Therapeutic Market: Focus on Format, Disease Area, Route of Administration, End Users, Region, and Competitive Landscape - Analysis and Forecast, 2024-2033" report has been added to  ResearchAndMarkets.com's offering. The global...

at 11:30
XtalPi Inc., a leading global technology company in integrating artificial intelligence (AI) and robotics to advance the discovery of groundbreaking medicine and innovative materials, announced today the launch of its proprietary comprehensive solid...



News published on and distributed by: